QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

UTHR

QT62United Therapeutics Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
536.59
-14.88-2.70%
OverviewShort InterestFilings
UTHRQT62United Therapeutics Corporation·NASDAQ
OverviewShort InterestFilings
536.59-2.70%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96BNTX-1.44%$90.89RPRX-1.38%$52.96
Snapshot
Index-P/E18.63EPS (ttm)
27.05
Insider Own1.29%
Shs Outstand42.45M
Perf Week-1.62%
Market Cap23.41BForward P/E16.20EPS next Y33.12Insider Trans0.91%Shs Float-Perf Month-5.33%
Enterprise Value22.33BPEG2.34EPS next Q7.17Inst Own-Short Float-Perf Quarter1.82%
Income1.26BP/S7.38EPS this Y4.90%Inst Trans-Short Ratio-Perf Half Y7.32%
Sales3.17BP/B4.07EPS next Y16.71%ROA19.17%Short Interest-Perf YTD10.13%
Book/sh134.20P/C15.35EPS next 5Y20.14%ROE19.24%52W High609.35 -11.94%Perf Year87.04%
Cash/sh70.01P/FCF23.02EPS past 3/5Y-ROIC18.81%52W Low272.12 97.19%Perf 3Y-
Dividend Est.-EV/EBITDA13.03Sales past 3/5Y18.03% 16.50%Gross Margin86.58%Volatility1.69% 1.70%Perf 5Y-
Dividend TTM-EV/Sales7.05EPS Y/Y TTM9.94%Oper. Margin45.34%ATR (14)13.65Perf 10Y-
Dividend Ex-Date-Quick Ratio4.50Sales Y/Y TTM10.22%Profit Margin40.61%RSI (14)38.37Recom2.25
Dividend Gr. 3/5Y-Current Ratio4.79EPS Q/Q-12.22%SMA20-2.91%Beta0.10Target Price636.83
Payout0.00%Debt/Eq0.00Sales Q/Q-1.51%SMA50-5.10%Rel Volume3.49Prev Close551.47
Employees1,305LT Debt/Eq0.05EarningsJul 29SMA2007.86%Avg Volume472.06KPrice536.59
IPO DateJun 17, 1999Option/ShortYes / YesEPS/Sales Surpr.-16.86% -1.88%Net Debt/EBITDA-0.63Volume1,645,718Change-2.70%
Analyst Ratings
DateActionAnalystRatingTarget
May-07-26ReiteratedMorgan StanleyEqual Weight$519 → $516
May-07-26ReiteratedWells FargoEqual Weight → Overweight$314 → $738
Apr-10-26InitiatedRaymond JamesOutperform$700
Apr-10-26ReiteratedMorgan StanleyEqual Weight$447 → $519
Mar-12-26ReiteratedCantor FitzgeraldOverweight$525 → $625
Feb-26-26ReiteratedH.C. WainwrightNeutral$525 → $600
Jan-06-26ReiteratedUBSBuy$580 → $645
Nov-19-25ReiteratedJefferiesBuy$564 → $575
Oct-30-25ReiteratedH.C. WainwrightNeutral$500 → $525
Oct-30-25ReiteratedRBC CapitalOutperform$569 → $587
Latest News
Jun-09-26
Jun-09-2601:35PM
These 3 Stocks Lowered Their Share Counts Drastically in Q1Yahoo
01:35PM
These 3 Stocks Lowered Their Share Counts Drastically in Q1Yahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,1713,1832,877
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A425384310
Gross Profit2,7452,7982,568
Selling, General and Administrative Excl. Other747731639
Research and Development540550481
Other Operating Expense20071
Operating Income1,4381,5171,377
Interest Expense162043
Unusual Expense
———
Non-Operating Income (Expense)-188-216-205
Net Income Before Taxes1,6081,7141,539
Income Taxes321379344
Consolidated Net Income1,2881,3351,195
Net Income From Continuing Operations1,2881,3351,195
Net Income1,2881,3351,195
EPS (Recurring)29.2730.1326.44
EPS (Basic, Before Extraordinaries)29.2730.1326.44
EPS (Diluted)27.0527.8624.64
EBITDA1,7141,8191,654
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio19.8417.49—
Price To Sales Ratio7.456.74—
Gross Margin86.5787.9089.26
Operating Margin45.3547.6647.86
Net Margin40.6241.9441.54
Shares Outstanding444445
Market Capitalization23,61021,439—
Operating Lease Expense
———
Insider Trading Volume
$580.48$515.89$451.29$386.70$322.11● Close Price0.00M31.45M62.90M94.35M125.80MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
ROTHBLATT MARTINE AChairperson & CEOJun 16 '26Sale549.809,5005,223,06840,513Jun 17 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 16 '26Option Exercise146.0319,0002,774,57050,013Jun 17 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 15 '26Sale549.159,5005,216,91840,513Jun 16 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 15 '26Option Exercise146.0319,0002,774,57050,013Jun 16 12:00 AM
EDGEMOND JAMESCFO AND TREASURERJun 15 '26Option Exercise117.7620,0002,355,20028,876Jun 16 12:00 AM
EDGEMOND JAMESCFO AND TREASURERJun 15 '26Sale549.1710,0005,491,74218,876Jun 16 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 12 '26Option Exercise146.0319,0002,774,57050,013Jun 15 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 12 '26Sale541.399,5005,143,21540,513Jun 15 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 11 '26Sale549.239,5005,217,68540,513Jun 12 12:00 AM
EDGEMOND JAMESCFO AND TREASURERJun 11 '26Option Exercise117.7620,0002,355,20028,876Jun 12 12:00 AM
EDGEMOND JAMESCFO AND TREASURERJun 11 '26Sale549.2910,0005,492,89318,876Jun 12 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 11 '26Option Exercise146.0319,0002,774,57050,410Jun 12 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 10 '26Sale545.839,5005,185,36540,513Jun 11 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 10 '26Option Exercise146.0319,0002,774,57059,910Jun 11 12:00 AM
ROTHBLATT MARTINE AChairperson & CEOJun 09 '26Sale549.329,5005,218,53440,513Jun 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR